BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 26578880)

  • 21. Astrocytes and Microglia as Potential Contributors to the Pathogenesis of
    Rostalski H; Leskelä S; Huber N; Katisko K; Cajanus A; Solje E; Marttinen M; Natunen T; Remes AM; Hiltunen M; Haapasalo A
    Front Neurosci; 2019; 13():486. PubMed ID: 31156371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
    Neumann M
    Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FTD and ALS: a tale of two diseases.
    Ferrari R; Kapogiannis D; Huey ED; Momeni P
    Curr Alzheimer Res; 2011 May; 8(3):273-94. PubMed ID: 21222600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligodendrocytes in amyotrophic lateral sclerosis and frontotemporal dementia: the new players on stage.
    Jamet M; Dupuis L; Gonzalez De Aguilar JL
    Front Mol Neurosci; 2024; 17():1375330. PubMed ID: 38585368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TBK1 mutation frequencies in French frontotemporal dementia and amyotrophic lateral sclerosis cohorts.
    Le Ber I; De Septenville A; Millecamps S; Camuzat A; Caroppo P; Couratier P; Blanc F; Lacomblez L; Sellal F; Fleury MC; Meininger V; Cazeneuve C; Clot F; Flabeau O; LeGuern E; Brice A;
    Neurobiol Aging; 2015 Nov; 36(11):3116.e5-3116.e8. PubMed ID: 26476236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of VCP Mutations in the Spectrum of Amyotrophic Lateral Sclerosis-Frontotemporal Dementia.
    Scarian E; Fiamingo G; Diamanti L; Palmieri I; Gagliardi S; Pansarasa O
    Front Neurol; 2022; 13():841394. PubMed ID: 35273561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS?
    Aulas A; Vande Velde C
    Front Cell Neurosci; 2015; 9():423. PubMed ID: 26557057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation in ALS/FTD pathogenesis.
    McCauley ME; Baloh RH
    Acta Neuropathol; 2019 May; 137(5):715-730. PubMed ID: 30465257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Overlapping features of frontotemporal dementia and amyotrophic lateral sclerosis].
    Lillo P; Matamala JM; Valenzuela D; Verdugo R; Castillo JL; Ibáñez A; Slachevsky A
    Rev Med Chil; 2014 Jul; 142(7):867-79. PubMed ID: 25378006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA Damage and Repair Deficiency in ALS/FTD-Associated Neurodegeneration: From Molecular Mechanisms to Therapeutic Implication.
    Wang H; Kodavati M; Britz GW; Hegde ML
    Front Mol Neurosci; 2021; 14():784361. PubMed ID: 34975400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions.
    Kumar V; Islam A; Hassan MI; Ahmad F
    Biochim Biophys Acta; 2016 Sep; 1862(9):1742-54. PubMed ID: 27318084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondria Dysfunction in Frontotemporal Dementia/Amyotrophic Lateral Sclerosis: Lessons From
    Anoar S; Woodling NS; Niccoli T
    Front Neurosci; 2021; 15():786076. PubMed ID: 34899176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease.
    Gelon PA; Dutchak PA; Sephton CF
    Front Mol Neurosci; 2022; 15():1000183. PubMed ID: 36263379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia: common pathways in neurodegenerative disease.
    Talbot K; Ansorge O
    Hum Mol Genet; 2006 Oct; 15 Spec No 2():R182-7. PubMed ID: 16987882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frontotemporal dementia: a bridge between dementia and neuromuscular disease.
    Ng AS; Rademakers R; Miller BL
    Ann N Y Acad Sci; 2015 Mar; 1338(1):71-93. PubMed ID: 25557955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deciphering genetic interactions between ALS genes using C. elegans.
    Therrien M; Parker JA
    Worm; 2014; 3():e29047. PubMed ID: 25254150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Weishaupt JH; Hyman T; Dikic I
    Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of PML nuclear bodies in familial amyotrophic lateral sclerosis-frontotemporal dementia.
    Antoniani F; Cimino M; Mediani L; Vinet J; Verde EM; Secco V; Yamoah A; Tripathi P; Aronica E; Cicardi ME; Trotti D; Sterneckert J; Goswami A; Carra S
    Cell Death Discov; 2023 Jul; 9(1):248. PubMed ID: 37454169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From FUS to Fibs: what's new in frontotemporal dementia?
    Burrell JR; Hodges JR
    J Alzheimers Dis; 2010; 21(2):349-60. PubMed ID: 20413882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD).
    Lattante S; Ciura S; Rouleau GA; Kabashi E
    Trends Genet; 2015 May; 31(5):263-73. PubMed ID: 25869998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.